Alright going through last years 10k and I’m try
Post# of 148126
“This is a Phase 2 trial to test the safety and efficacy of leronlimab on 22 different solid tumor cancers, including brain-glioblastoma, melanoma, lung, breast, ovarian, pancreas, bladder, throat, stomach, colon, testicular, uterine, among other indications. The first patient was treated in April 2020. Nine patients either reached one year or surpassed one year of treatment with leronlimab.The trial will conclude in 2021. A planned trial relating to colorectal cancer was combined into this trial.”
Alight so if you read this more specifically “The trial will conclude in 2021. A planned trial relating to colorectal cancer was combined into this trial”
So let me ask you this. How is a planned trial included ? Is it possible that we a separate blinded small trial for colon cancer this entire time with the SOC and maybe their was strong results with this. Literally nobody has talked about this unless I’m that dense and missed it.
I’m just trying to figure out how their is a trial within a trial ?